Amit Dalal of Amit Nalin Securities is positive on FMCG space.
Dalal told CNBC-TV18, "I remain very positive on healthcare and FMCG sector. But they are not going to be sectors, which are going to give you high momentum growth or something like a land bank profit coming in. But if you take the McKinsey Report for domestic Pharma, the growth is underwritten for the next 5-7 years."
He further added, "When we are talking of healthcare, we are talking about hospitals and development of chain of hospitals like Wockhardt or Fortis or Indraprastha Medical , which is in that same space. I think there is so much opportunity because of the dearth of such facilities of high quality, which India definitely needs. So in terms of their development process, I think they are still in very nascent stages and you will see tremendous change coming over the next 2-3 years. If you are looking for opportunity to invest on a longer basis and everything now we are discounting on a '09-10 basis, so why not this space also."
Disclosure: It is safe to assume that analyst and his clients may have an investment interest in the above stock.
